Anna Zagorska

Company: Gilead Sciences

Job title: Director, Inflammation & Fibrosis

Seminars:

The Big Debate: Pan-Antifibrotics, Fact or Fiction? Dissecting Mechanisms & Organ Specificity & Strategies for Cross-Tissue Success 2:00 pm - 4:00 pm

As interest grows in developing antifibrotics with cross-indication potential, this workshop critically examines whether a true “pan-antifibrotic” is biologically and clinically feasible. Through real-world data, mechanistic comparisons, and forward-looking trial design strategies, we’ll explore what it would take to deliver a truly universal fibrosismodifying therapy. This workshop will gather experts to discuss: Reviewing trials of…Read more

day: Pre-Conference Day

Leveraging Common Cross-Tissue Fibrotic Mechanisms to Validate Drug Candidates 12:30 pm

Identifying common fibrotic mechanisms across liver, lung and kidney fibrosis to enable a unified approach to anti-fibrotic discovery and accelerate drug development Using precision cut lung slices, multi omics to provide a highly physiologically relevant model enhances predictive accuracy of physiologically relevant models Leveraging reverse translation to ensure alignment between preclinical studies and human disease…Read more

day: Conference Day One